{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T13:54:14Z","timestamp":1766066054091},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2010,10,13]],"date-time":"2010-10-13T00:00:00Z","timestamp":1286928000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1007\/s11060-010-0434-z","type":"journal-article","created":{"date-parts":[[2010,10,14]],"date-time":"2010-10-14T03:56:48Z","timestamp":1287028608000},"page":"629-634","source":"Crossref","is-referenced-by-count":8,"title":["Topotecan and ifosfamide systemic chemotherapy for CNS involvement of solid tumors"],"prefix":"10.1007","volume":"103","author":[{"given":"Philipp","family":"Kiewe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eckhard","family":"Thiel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Reinwald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnieszka","family":"Korfel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,10,13]]},"reference":[{"key":"434_CR1","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1200\/JCO.2004.12.149","volume":"22","author":"JS Barnholtz-Sloan","year":"2004","unstructured":"Barnholtz-Sloan JS, Sloan AE, Davis FG, Vigneau FD, Sawaya RE (2004) Incidence proportions of brain metastases in patients diagnosed (1973\u20132001) in the metropolitan detroit cancer surveillance system. J Clin Oncol 22:2865\u20132872","journal-title":"J Clin Oncol"},{"key":"434_CR2","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0360-3016(98)00442-8","volume":"43","author":"FJ Lagerwaard","year":"1999","unstructured":"Lagerwaard FJ, Levendag PC, Nowak PJ, Eijkenboom WM, Hanssens PE, Schmitz PI (1999) Identification of prognostic factors in patients with brain metastases: a review of 1292 patients. Int J Radiat Oncol Biol Phys 43:795\u2013803","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"434_CR3","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1634\/theoncologist.12-7-884","volume":"12","author":"AF Eichler","year":"2007","unstructured":"Eichler AF, Loeffler JS (2007) Multidisciplinary management of brain metastases. Oncologist 12:884\u2013898","journal-title":"Oncologist"},{"key":"434_CR4","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJM199002223220802","volume":"322","author":"RA Patchell","year":"1990","unstructured":"Patchell RA, Tibbs PA, Walsh JW et al (1990) A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 322:494\u2013500","journal-title":"N Engl J Med"},{"key":"434_CR5","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/ana.410330605","volume":"33","author":"CJ Vecht","year":"1993","unstructured":"Vecht CJ, Haaxma-Reiche H, Noordijk EM et al (1993) Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery? Ann Neurol 33:583\u2013590","journal-title":"Ann Neurol"},{"key":"434_CR6","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3171\/jns.1993.79.2.0210","volume":"79","author":"RK Bindal","year":"1993","unstructured":"Bindal RK, Sawaya R, Leavens ME, Lee JJ (1993) Surgical treatment of multiple brain metastases. J Neurosurg 79:210\u2013216","journal-title":"J Neurosurg"},{"key":"434_CR7","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.ijrobp.2007.06.074","volume":"70","author":"PW Sperduto","year":"2008","unstructured":"Sperduto PW, Berkey B, Gaspar LE, Mehta M, Curran W (2008) A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database. Int J Radiat Oncol Biol Phys 70:510\u2013514","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"434_CR8","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.ijrobp.2009.08.025","volume":"77","author":"PW Sperduto","year":"2010","unstructured":"Sperduto PW, Chao ST, Sneed PK et al (2010) Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4, 259 patients. Int J Radiat Oncol Biol Phys 77:655\u2013661","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"434_CR9","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/1097-0142(19820215)49:4<759::AID-CNCR2820490427>3.0.CO;2-7","volume":"49","author":"WR Wasserstrom","year":"1982","unstructured":"Wasserstrom WR, Glass JP, Posner JB (1982) Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients. Cancer 49:759\u2013772","journal-title":"Cancer"},{"key":"434_CR10","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1634\/theoncologist.2008-0138","volume":"13","author":"MC Chamberlain","year":"2008","unstructured":"Chamberlain MC (2008) Neoplastic meningitis. Oncologist 13:967\u2013977","journal-title":"Oncologist"},{"key":"434_CR11","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/BF00688317","volume":"37","author":"SD Baker","year":"1996","unstructured":"Baker SD, Heideman RL, Crom WR, Kuttesch JF, Gajjar A, Stewart CF (1996) Cerebrospinal fluid pharmacokinetics and penetration of continuous infusion topotecan in children with central nervous system tumors. Cancer Chemother Pharmacol 37:195\u2013202","journal-title":"Cancer Chemother Pharmacol"},{"key":"434_CR12","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2165\/00003088-199631020-00001","volume":"31","author":"VM Herben","year":"1996","unstructured":"Herben VM, ten Bokkel Huinink WW, Beijnen JH (1996) Clinical pharmacokinetics of topotecan. Clin Pharmacokinet 31:85\u2013102","journal-title":"Clin Pharmacokinet"},{"key":"434_CR13","doi-asserted-by":"crossref","unstructured":"Kiewe P, Neumann M, Wagner T et al (2010) Penetration of ifosfamide and its active metabolite 4-OH-ifosfamide into cerebrospinal fluid of patients with CNS malignancies. Cancer Chemother Pharmacol Feb 24. [Epub ahead of print]","DOI":"10.1007\/s00280-010-1274-4"},{"key":"434_CR14","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1200\/JCO.1997.15.1.148","volume":"15","author":"JR Murren","year":"1997","unstructured":"Murren JR, Anderson S, Fedele J et al (1997) Dose-escalation and pharmacodynamic study of topotecan in combination with cyclophosphamide in patients with refractory cancer. J Clin Oncol 15:148\u2013157","journal-title":"J Clin Oncol"},{"key":"434_CR15","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1159\/000055088","volume":"24","author":"C Oberhoff","year":"2001","unstructured":"Oberhoff C, Kieback DG, Wurstlein R et al (2001) Topotecan chemotherapy in patients with breast cancer and brain metastases: results of a pilot study. Onkologie 24:256\u2013260","journal-title":"Onkologie"},{"key":"434_CR16","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1634\/theoncologist.9-1-68","volume":"9","author":"ET Wong","year":"2004","unstructured":"Wong ET, Berkenblit A (2004) The role of topotecan in the treatment of brain metastases. Oncologist 9:68\u201379","journal-title":"Oncologist"},{"key":"434_CR17","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1016\/S0959-8049(02)00140-5","volume":"38","author":"A Korfel","year":"2002","unstructured":"Korfel A, Oehm C, von Pawel J et al (2002) Response to topotecan of symptomatic brain metastases of small-cell lung cancer also after whole-brain irradiation. A multicentre phase II study. Eur J Cancer 38:1724\u20131729","journal-title":"Eur J Cancer"},{"key":"434_CR18","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1038\/sj.bjc.6601861","volume":"90","author":"T Kerbusch","year":"2004","unstructured":"Kerbusch T, Groenewegen G, Math\u00f4t RA et al (2004) Phase I and pharmacokinetic study of the combination of topotecan and ifosfamide administered intravenously every 3\u00a0weeks. Br J Cancer 90:2268\u20132277","journal-title":"Br J Cancer"},{"key":"434_CR19","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00432-002-0337-2","volume":"128","author":"CP Schneider","year":"2002","unstructured":"Schneider CP, Merkel U, Gr\u00fcbner U, Kath R, H\u00f6ffken K, Hoffmann A (2002) Phase I clinical and pharmacokinetic study of combination chemotherapy with topotecan and ifosfamide in patients with progressive or relapsed solid tumors. J Cancer Res Clin Oncol 128:313\u2013318","journal-title":"J Cancer Res Clin Oncol"},{"key":"434_CR20","first-page":"1927","volume":"17","author":"MJ Smith","year":"1998","unstructured":"Smith MJ, Spencer SA, Zhang R, Robert F (1998) Phase I\/IIa study of sequential ifosfamide (I) and topotecan (T) in patients with small cell lung cancer (SCLC). Proc ASCO 17:1927","journal-title":"Proc ASCO"},{"key":"434_CR21","first-page":"1547","volume":"14","author":"V Lorusso","year":"2005","unstructured":"Lorusso V, Gebbia V, Spada M et al (2005) Topotecan plus ifosfamide in patients with platinum refractory advanced\/metastatic non-small cell lung cancer: a phase II trial. Oncol Rep 14:1547\u20131551","journal-title":"Oncol Rep"},{"key":"434_CR22","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.ygyno.2004.01.027","volume":"93","author":"S Chiara","year":"2004","unstructured":"Chiara S, Tognoni A, Pastrone I et al (2004) Topotecan and ifosfamide as salvage treatment in advanced ovarian cancer. Gynecol Oncol 93:474\u2013478","journal-title":"Gynecol Oncol"},{"key":"434_CR23","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","volume":"47","author":"AB Miller","year":"1981","unstructured":"Miller AB, Hoogstraten B, Staquet M, Winkler A (1981) Reporting results of cancer treatment. Cancer 47:207\u2013214","journal-title":"Cancer"},{"key":"434_CR24","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1159\/000012185","volume":"59","author":"A Fujitaa","year":"2000","unstructured":"Fujitaa A, Fukuoka S, Takabatakea H, Tagakia S, Sekine K (2000) Combination chemotherapy of cisplatin, ifosfamide, and irinotecan with rhG-CSF support in patients with brain metastases from non-small cell lung cancer. Oncology 59:291\u2013295","journal-title":"Oncology"},{"key":"434_CR25","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/annonc\/mdp343","volume":"21","author":"S Siena","year":"2010","unstructured":"Siena S, Crin\u00f2 L, Danova M et al (2010) Dose-dense temozolomide regimen for the treatment of brain metastases from melanoma, breast cancer, or lung cancer not amenable to surgery or radiosurgery: a multicenter phase II study. Ann Oncol 21:655\u2013661","journal-title":"Ann Oncol"},{"key":"434_CR26","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1200\/JCO.2007.12.3588","volume":"26","author":"NU Lin","year":"2008","unstructured":"Lin NU, Carey LA, Liu MC et al (2008) Phase II trial of lapatinib for brain metastases in patients with human epidermal growth factor receptor 2-positive breast cancer. J Clin Oncol 26:1993\u20131999","journal-title":"J Clin Oncol"},{"key":"434_CR27","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1002\/(SICI)1097-0142(19980501)82:9<1764::AID-CNCR24>3.0.CO;2-1","volume":"82","author":"F Bokstein","year":"1998","unstructured":"Bokstein F, Lossos A, Siegal T (1998) Leptomeningeal metastases from solid tumors: a comparison of two prospective series treated with and without intra-cerebrospinal fluid chemotherapy. Cancer 82:1756\u20131763","journal-title":"Cancer"},{"key":"434_CR28","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1200\/JCO.1998.16.4.1561","volume":"16","author":"MJ Glantz","year":"1998","unstructured":"Glantz MJ, Cole BF, Recht L et al (1998) High-dose intravenous methotrexate for patients with nonleukemic leptomeningeal cancer: is intrathecal chemotherapy necessary? J Clin Oncol 16:1561\u20131567","journal-title":"J Clin Oncol"},{"key":"434_CR29","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3816\/CBC.2006.n.028","volume":"7","author":"YL Tham","year":"2006","unstructured":"Tham YL, Hinckley L, Teh BS, Elledge R (2006) Long-term clinical response in leptomeningeal metastases from breast cancer treated with capecitabine monotherapy: a case report. Clin Breast Cancer 7:164\u2013166","journal-title":"Clin Breast Cancer"},{"key":"434_CR30","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1212\/WNL.55.1.117","volume":"55","author":"W Boogerd","year":"2000","unstructured":"Boogerd W, Dorresteijn LDA, van Der Sande JJ, de Gast GC, Bruning PF (2000) Response of leptomeningeal metastases from breast cancer to hormonal therapy. Neurology 55:117\u2013119","journal-title":"Neurology"},{"key":"434_CR31","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00277-008-0575-8","volume":"88","author":"L Fischer","year":"2009","unstructured":"Fischer L, Korfel A, Kiewe P, Neumann M, Jahnke K, Thiel E (2009) Systemic high-dose methotrexate plus ifosfamide is highly effective for central nervous system (CNS) involvement of lymphoma. Ann Hematol 88:133\u2013139","journal-title":"Ann Hematol"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-010-0434-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-010-0434-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-010-0434-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T12:54:43Z","timestamp":1559739283000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-010-0434-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,13]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["434"],"URL":"https:\/\/doi.org\/10.1007\/s11060-010-0434-z","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,13]]}}}